Karuna Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Karuna Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Amount of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2022-02-24
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-12-31 was $0.00.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-06-30 was $2.09M.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2019-03-31 was $5.02M.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2021 was $0.00.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2019 was $7.10M, a 72.78% decline from fiscal 2018.
- Karuna Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2018 was $26.09M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $2.09M derived: sum of 3 quarters · filed 2022-02-24 | $7.10M 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.09M derived: sum of 2 quarters · filed 2020-11-05 | $7.10M 10-Q · filed 2020-11-05 | $7.10M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $7.10M 10-Q · filed 2020-08-05 | $7.10M derived: sum of 3 quarters · filed 2020-08-05 | $22.89M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $5.02M 10-Q · filed 2020-05-07 | $5.02M derived: sum of 2 quarters · filed 2020-05-07 | $20.80M derived: sum of 3 quarters · filed 2020-05-07 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $15.78M 10-Q · filed 2019-08-08 | $26.09M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $15.78M 10-Q · filed 2019-11-07 | $26.09M 10-Q · filed 2019-11-07 |